Cancer cell international, vol.11, no.1, pp.18, 2011 (SCI-Expanded)
Article / Article
Cancer cell international
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated:
Background: Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imatinib mesylate (IM) on human GBM in vitro and the role of midkine (MK) in this new combination treatment.